MétaCan
Menu
Back to cohort
Record W7135036575 · doi:10.1093/neuped/wuaf001.186

LGG-03. Revealing MAPK-Activated Immune-Suppressive Myeloid Populations in Pediatric Low-Grade Gliomas Through Spatial Immune Mapping

2025· article· en· W7135036575 on OpenAlexaff
Augusto Faria Andrade, Romain Sigaud, Evan Puligandla, Bridget Liu, Elham Karimi, Alva Annett, Morteza Rezanejad, Simone Schmid, Florian Selt, P. Hern�iz Driever, Svea Horn, Philipp Sievers, Marco Prinz, Markus Glatzel, C. Mawrin, Christian Hartmann, Camelia‐Maria Monoranu, Felix Sahm, Stefan M Pfister, O Witt, David T W Jones, Arend Koch, Claudia L. Kleinman, David Capper, Logan A. Walsh, N Jabado, Till Milde

Bibliographic record

VenueNeuro-Oncology Pediatrics · 2025
Typearticle
Languageen
FieldMedicine
TopicGlioma Diagnosis and Treatment
Canadian institutionsJewish General HospitalMcGill UniversityMcGill University Health CentreUniversity of Calgary
Fundersnot available
KeywordsMyeloidImmune systemMass cytometryImmunophenotypingMyeloid leukemiaPopulationMicrogliaTumor microenvironment

Abstract

fetched live from OpenAlex

Abstract Pediatric low-grade gliomas (pLGG), the most common brain tumors in children, remain a significant cause of morbidity. Therefore, novel therapeutic strategies are urgently needed. Although some studies have characterized the tumor microenvironment (TME) of pLGG using bulk and/or single-cell RNA sequencing, little is known about the spatial proteomic architecture of pLGG and its relationship to clinico-molecular features. Our study utilized imaging mass cytometry and a panel of 28 metal-labeled antibodies to unravel the spatial organization of 120 primary pLGG samples from the LOGGIC Core BioClinical DataBank. Cellular neighborhood analysis mapped the spatial organization of pLGG TME and several clinical features (entity, tumor location, disease progression status, age and sex) were used to measure their putative association with the enrichment of key cell populations and structures. Here, we revealed myeloid cells - comprising resident microglia and diverse bone marrow-derived macrophages - as the predominant immune population in the TME, notably in optic pathway tumors, alongside limited T-lymphoid infiltrates. Importantly, we identified an immunophenotype signature based on the presence of myeloid cell populations that was significantly associated with disease progression in our cohort. Clinically, the myeloid cell populations, together with an increased expression of the immune checkpoint protein TIM-3, suggest the presence of an immunosuppressive environment. Notably, p-ERK positivity was high in the myeloid populations, indicating a possible link between TIM-3 and MAPK activity in myeloid cells. Spatial analysis unveiled intriguing cell interactions, including noteworthy myeloid interactions, and specific cellular neighborhoods consistently associated with progression-free survival (PFS) in all patients, and particularly those at risk of progression. Our study, the largest on pLGG TME to date, highlights the immunosuppressive role of diverse myeloid infiltrates and suggests combining TIM-3 with MAPK inhibition as a promising therapeutic strategy targeting both the TME and oncogenic MAPK activation in these debilitating tumors.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.033
GPT teacher head0.316
Teacher spread0.283 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-Oncology PediatricsSame topicGlioma Diagnosis and TreatmentFrench-language works237,207